Evidence map›Paper›PMID 30003361›Full record

ArticleInternational journal of colorectal disease2018

Increased risk of periodontitis among patients with Crohn's disease: a population-based matched-cohort study.

Ying-Chen Chi, Jiunn-Liang Chen, Li-Hsuan Wang, Koyin Chang, Chen-Long Wu, Shu-Yi Lin, Joseph Jordan Keller, Chyi-Huey Bai

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 5 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Ying-Chen ChiDepartment of Healthcare Information and Management, Ming Chuan University, Taoyuan, Taiwan.
Jiunn-Liang ChenDepartment of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Li-Hsuan WangSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Koyin ChangDepartment of Healthcare Information and Management, Ming Chuan University, Taoyuan, Taiwan.
Chen-Long WuDepartment of Pediatrics, Landseed Hospital, Taoyuan, Taiwan.
Shu-Yi LinDepartment of Education & Research, Taipei City Hospital, Taipei City, Taiwan.
Joseph Jordan KellerSchool of Public Health, College of Medicine, College of Public Health and Nutrition, Taipei Medical University, 250 Wu-Hsing St, Taipei, 110, Taiwan. Joseph.Jordan.Keller@gmail.com.
Chyi-Huey BaiInternational Master's Program, College of Health Technology, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Taipei City Hospital · TWTaipei Medical University · TWLandseed Hospital · TWMing Chuan University · TWMin-Hwei College of Health Care Management · TWNational Taipei University of Nursing and Health Science · TW

Funding

NA NA
6 · The paper itself

Abstract

backgroundPeriodontitis is a frequently cited extraintestinal manifestation of Crohn's disease (CD). Despite a plethora of investigations and a recent meta-analysis linking CD and periodontitis, no study has estimated the risk of periodontitis among CD patients with respect to a comparison group nor has any investigation analyzed the effect of CD-specific medications on the risk of periodontitis. The present cohort study compared CD patients and matched subjects without a history of inflammatory bowel disease (IBD) to estimate the effect of CD and CD-specific pharmaceutical prescriptions on the risk of developing periodontitis by leveraging a population-based dataset in Taiwan.

methodsWe sourced 6657 CD patients and 26,628 comparison subjects without a history of IBD from the Taiwan National Health Insurance Database. Cox proportional hazards regressions were used to estimate the risk of subsequent periodontitis by CD status and pharmaceutical prescription during the follow-up period.

resultsAfter adjusting for socioeconomic status (SES), urbanicity, selected medical co-morbidities, and CD-specific pharmaceutical prescriptions, the hazard ratio (HR) for subsequent periodontitis among patients with CD was 1.36 (95% CI = 1.25-1.48) that of comparison subjects. There was not a significant difference in risk between genders or across ages. Steroids (95% CI = 0.66-0.77) appeared to confer a protective effect and Aspirin, Plavix, and Licodin were marginally protective (95% CI = 0.76-0.95).

conclusionThis is the first study to report an increased HR for subsequent periodontitis among CD patients when compared to matched comparison subjects without IBD. The protective effect of some pharmaceuticals may suggest that treatment of CD protects against periodontitis.

Indexed as

Crohn DiseasePeriodontitisAdultAgedCase-Control StudiesComorbidityFemaleGlucocorticoidsHumansMaleMiddle AgedProportional Hazards ModelsProtective AgentsRisk AssessmentRisk FactorsSocioeconomic FactorsGlucocorticoidsProtective AgentsCrohn’s diseaseEpidemiologyPeriodontitis

Identifiers

PMID30003361
OpenAlexW2864108759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.